tirzepatide vision changes Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Tirzepatide and Macular Degeneration: Current

When estrogen levels start to fall during perimenopause, so do its effects on your appetite

Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs

Remember, weight loss with this treatment is generally gradual and steady, rather than rapid

So I'm also the super excited about omics, right